Kristin Abate
Förmögenhet: 12 324 $ per 2026-10-31
Förmögenhet: 12 324 $ per 2026-10-31
Kristin Abate is currently Chief Accounting Officer & Executive VP at Karyopharm Therapeutics, Inc., a position held since 2025.
Education includes graduate studies at Boston College and undergraduate studies at Bryant University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-10-16 | 18 616 ( 0,08 % ) | 12 324 $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Comptroller/Controller/Revisor | 2019-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån